Clinical trial
Dose determination of Taxotere�, Eloxatin� and Xeloda� (TEX) in combination with Herpectin� as first line treatment to patients with HER2-positive non-resectable esophagus, cardia or gastric cancer
To determine maximum tolerable dose (MTD) for the combination regime TEX (docetaxel, oxaliplatin and capecitabine) + trastuzumab and to evaluate the toxicity
| Category | Value |
|---|---|
| Study start date | 2010-12-06 |